MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +75

What to Expect From MetLife's Q1 2026 Earnings Report

AI-generated analysis

📈 MetLife (MET) is expected to report fiscal Q1 2026 earnings with diluted EPS of $2.21, representing a 12.8% increase from the prior year quarter.

💰 Full-year analysts estimate MET will post $9.86 EPS in fiscal 2026 and $10.99 EPS for fiscal 2027, reflecting double-digit projected growth.

📊 Previous Q4 2025 results showed adjusted EPS of $2.49 and revenue growth of 27.6% to $23.8 billion following the Feb. 4 announcement.

📉 MET stock has underperformed the S&P 500 and Financial Select Sector ETF over the past 52 weeks, gaining only 8.7% versus 36.1% and 16.6% respectively.

🏦 The company provides insurance, annuities, employee benefits, and asset management services globally with a market cap of $46.4 billion.

⚖️ Analyst sentiment is generally bullish with an average price target of $91.44, implying roughly 23% upside from current levels.

📝 Of 19 analysts covering MET, the ratings are split between multiple strong buy recommendations and seven holds.

❗ Previous quarters show mixed analyst performance records, with MET beating consensus in two quarters while missing forecasts in two others.

Bullish Signals
  • MetLife expects fiscal first-quarter 2026 profit of $2.21 per share, representing a strong 12.8% increase from $1.96 per share in the same quarter last year.
  • For the full fiscal year, analysts forecast MET to report EPS of $9.86, which is up 10.9% from $8.89 in fiscal 2025.
  • Long-term growth is visible with EPS projected to rise 11.5% year over year to $10.99 in fiscal 2027.
  • Recent Q4 performance demonstrated robust momentum, with adjusted EPS jumping 19.1% year over year to $2.49 and revenue surging 27.6% to $23.8 billion.
  • The analyst consensus is moderately bullish with an average price target of $91.44, indicating a potential upside of 23% from current levels.
  • Of the 19 analysts covering MetLife, 11 advise a 'Strong Buy' rating and only 7 give a 'Hold', reflecting positive sentiment.
Risk Factors
  • MET stock has underperformed the S&P 500 Index's 36.1% gains over the past 52 weeks, rising only 8.7% during the same period.
  • The stock also lagged behind the State Street Financial Select Sector SPDR ETF's (XLF) 16.6% returns over the last year.
  • Analyst consensus is mixed with seven analysts rating the stock a 'Hold,' signaling lingering uncertainty despite overall bullish sentiment.
  • Historical performance shows inconsistency, with the company beating forecasts in only two of its last four quarters while missing on two others.
Full Analysis
New York-based MetLife, Inc. (MET) is preparing to announce its fiscal first-quarter earnings for 2026, with analysts projecting the company will beat consensus estimates based on recent performance trends. MET is a global financial services provider operating across insurance, annuities, employee benefits, and asset management, with a current market capitalization of $46.4 billion. Regarding the upcoming Q1 report, Wall Street expects the company to report a diluted profit of $2.21 per share, representing a 12.8% increase from $1.96 per share in the same quarter last year. Over the past four quarters prior to this announcement, MetLife has consistently beaten estimates in two instances while missing forecasts on two others, suggesting a volatile but generally positive analyst reception. For full-year outlooks, analysts anticipate MET will report earnings per share (EPS) of $9.86 for the current fiscal year, which would mark an 10.9% rise from the $8.89 reported in fiscal 2025. Growth is projected to continue into the next fiscal period, with EPS expected to reach $10.99 in fiscal 2027, reflecting an 11.5% year-over-year increase. The company's stock has historically underperformed broader market indices, posting only an 8.7% gain over the past 52 weeks compared to the S&P 500 Index’s 36.1% rally and the State Street Financial Select Sector SPDR ETF’s (XLF) 16.6% return. Most recently, following its Q4 results on February 4, shares rose 1.4% after adjusted EPS of $2.49 and a 27.6% revenue increase to $23.8 billion were reported. Investor sentiment remains favorable, with MET receiving an overall "Moderate Buy" rating from the analyst community. Of the 19 analysts covering the stock, 11 maintain a "Strong Buy" stance, while one suggests a "Moderate Buy" and seven recommend a "Hold." The average analyst price target is set at $91.44, which implies approximately 23% upside from current trading levels. Beyond earnings, other market updates include potential calendar reminders for April regarding major consumer stocks and commentary on housing redesigns by Mark Cuban, though these are tangential to MetLife's specific financial performance.